Literature DB >> 17000756

Regulation of p53 localization and activity by Ubc13.

Aaron Laine1, Ivan Topisirovic, Dayong Zhai, John C Reed, Katherine L B Borden, Ze'ev Ronai.   

Abstract

The abundance and activity of p53 are regulated largely by ubiquitin ligases. Here we demonstrate a previously undisclosed regulation of p53 localization and activity by Ubc13, an E2 ubiquitin-conjugating enzyme. While increasing p53 stability, Ubc13 decreases p53 transcriptional activity and increases its localization to the cytoplasm, changes that require its ubiquitin-conjugating activity. Ubc13 elicits K63-dependent ubiquitination of p53, which attenuates Hdm2-induced polyubiquitination of p53. Ubc13 association with p53 requires an intact C-terminal domain of p53 and is markedly stronger with a p53 mutant that cannot tetramerize. Expression of Ubc13 in vivo increases the pool of monomeric p53, indicating that Ubc13 affects tetramerization of p53. Significantly, wild-type but not mutant Ubc13 is associated with polysomes and enriches p53 within this fraction. In response to DNA damage, Ubc13 is no longer capable of facilitating p53 monomerization, in part due to a decrease in its own levels which is p53 dependent. Our findings point to a newly discerned mechanism important in the regulation of p53 organization, localization, and activity by Ubc13.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17000756      PMCID: PMC1636826          DOI: 10.1128/MCB.01156-06

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  34 in total

1.  A leucine-rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking.

Authors:  J M Stommel; N D Marchenko; G S Jimenez; U M Moll; T J Hope; G M Wahl
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

2.  Regulation of p53 by the ubiquitin-conjugating enzymes UbcH5B/C in vivo.

Authors:  Mark K Saville; Alison Sparks; Dimitris P Xirodimas; Julie Wardrop; Lauren F Stevenson; Jean-Christophe Bourdon; Yvonne L Woods; David P Lane
Journal:  J Biol Chem       Date:  2004-07-26       Impact factor: 5.157

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

4.  Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.

Authors:  R Honda; H Tanaka; H Yasuda
Journal:  FEBS Lett       Date:  1997-12-22       Impact factor: 4.124

5.  Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain.

Authors:  M Treier; L M Staszewski; D Bohmann
Journal:  Cell       Date:  1994-09-09       Impact factor: 41.582

6.  Noncanonical MMS2-encoded ubiquitin-conjugating enzyme functions in assembly of novel polyubiquitin chains for DNA repair.

Authors:  R M Hofmann; C M Pickart
Journal:  Cell       Date:  1999-03-05       Impact factor: 41.582

7.  Regulation of p53 stability by Mdm2.

Authors:  M H Kubbutat; S N Jones; K H Vousden
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

8.  Mdm2 promotes the rapid degradation of p53.

Authors:  Y Haupt; R Maya; A Kazaz; M Oren
Journal:  Nature       Date:  1997-05-15       Impact factor: 49.962

9.  TIFA activates IkappaB kinase (IKK) by promoting oligomerization and ubiquitination of TRAF6.

Authors:  Chee-Kwee Ea; Lijun Sun; Jun-Ichiro Inoue; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

10.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

View more
  42 in total

Review 1.  Posttranslational modification of p53: cooperative integrators of function.

Authors:  David W Meek; Carl W Anderson
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-10-28       Impact factor: 10.005

2.  Structural and functional comparison of the RING domains of two p53 E3 ligases, Mdm2 and Pirh2.

Authors:  Jonathan Shloush; John E Vlassov; Ian Engson; Shili Duan; Vivian Saridakis; Sirano Dhe-Paganon; Brian Raught; Yi Sheng; Cheryl H Arrowsmith
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

Review 3.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

4.  Regulation of E2 promoter binding factor 1 (E2F1) transcriptional activity through a deubiquitinating enzyme, UCH37.

Authors:  Christina S Mahanic; Varija Budhavarapu; Joshua D Graves; Gang Li; Weei-Chin Lin
Journal:  J Biol Chem       Date:  2015-09-22       Impact factor: 5.157

5.  Ubiquitin over-expression promotes E6AP autodegradation and reactivation of the p53/MDM2 pathway in HeLa cells.

Authors:  Rita Crinelli; Marzia Bianchi; Michele Menotta; Elisa Carloni; Elisa Giacomini; Marzia Pennati; Mauro Magnani
Journal:  Mol Cell Biochem       Date:  2008-07-09       Impact factor: 3.396

6.  Control of p53 multimerization by Ubc13 is JNK-regulated.

Authors:  Ivan Topisirovic; Gustavo J Gutierrez; Meifan Chen; Ettore Appella; Katherine L B Borden; Ze'ev A Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

7.  The BM2 protein of influenza B virus interacts with p53 and inhibits its transcriptional and apoptotic activities.

Authors:  H Zhang; H Yu; J Wang; M Zhang; X Wang; W Ahmad; M Duan; Z Guan
Journal:  Mol Cell Biochem       Date:  2015-02-11       Impact factor: 3.396

8.  Yeast Chfr homologs retard cell cycle at G1 and G2/M via Ubc4 and Ubc13/Mms2-dependent ubiquitination.

Authors:  Greta L Loring; Kathryn C Christensen; Scott A Gerber; Charles Brenner
Journal:  Cell Cycle       Date:  2007-10-02       Impact factor: 4.534

9.  Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates.

Authors:  Tomás R Guilarte; Neal C Burton; Tatyana Verina; Vinaykumar V Prabhu; Kevin G Becker; Tore Syversen; Jay S Schneider
Journal:  J Neurochem       Date:  2008-02-13       Impact factor: 5.372

10.  Ubc13 dosage is critical for immunoglobulin gene conversion and gene targeting in vertebrate cells.

Authors:  Isin Ertongur; Nils-Sebastian Tomi; André Kutzera; Sabine Fischer-Burkart; Berit Jungnickel
Journal:  Nucleic Acids Res       Date:  2010-03-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.